Henrike M. Hamer

Clinical chemist
Department of Laboratory medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
Amsterdam, Noord-Holland, Netherlands

Presentation(s):

• OC 27.1 - Dominant negative effects of Gln50Arg mutation in the EGF-1 domain of factor IX causes severe Hemophilia B affecting factor IX replacement therapy

  Sunday, June 23, 2024
  14:45 – 15:00 ICT